Radiotherapy for Recurrent Sacrococcygeal Chordoma
Critical Context: Prior Radiation Status Determines Feasibility
- The European Society for Medical Oncology recommends that the feasibility and potential benefit of radiotherapy for recurrent sacrococcygeal chordoma depends entirely on whether the patient received prior radiation to the same anatomical area 1, 2
- For patients without prior radiation to the recurrence site, salvage radiotherapy with curative intent should be delivered using the same high-dose approach as primary treatment, requiring at least 74 GyE in conventional fractionation for photon and proton therapy 3, 4
Treatment Approaches
- Definitive radiotherapy alone is a reasonable alternative to surgery plus radiation for recurrent sacrococcygeal chordoma, although neither approach is very effective 1
- Re-irradiation is only feasible if high-dose radiation can be delivered without exceeding organ-at-risk dose constraints, which is often impossible in the sacral region 3, 5
- Carbon ion therapy may be considered for re-irradiation after initial low-LET treatment, as it may be more effective against radio-resistant clones selected by the first treatment 3, 5
Critical Pitfalls to Avoid
- The European Society for Medical Oncology advises against assuming radiotherapy alone offers meaningful cure rates for recurrent disease, as the evidence consistently shows cure is virtually impossible 1, 2
- The European Society for Medical Oncology recommends not proceeding with re-irradiation without accurate reconstruction of previous dose distribution and verification that organ-at-risk constraints can be respected 3
Recommended Approach for Recurrent Disease
- The treatment goal should shift from cure to palliation, with careful selection of interventions that balance morbidity and quality of life, as recommended by the European Society for Medical Oncology 1, 4
- For patients with multifocal recurrent disease, cure is virtually impossible and aggressive curative-intent treatment should not be performed, as advised by the European Society for Medical Oncology 1
- Palliative care should be incorporated from the beginning, including pain control, symptom management, and discussion of patient goals, as recommended by the European Society for Medical Oncology 5